Allocation concealment in clinical trials - Reply

被引：1

作者：

Balk, EM ^{[1
]}

Bonis, PAL

Lau, J

Ioannidis, JPA

机构：

[1] Tufts New England Med Ctr, Div Clin Care Res, Boston, MA 02111 USA

[2] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 288卷 / 19期

关键词：

D O I：

10.1001/jama.288.19.2408-JLT1120-4-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：2408 / 2409

页数：2

相关论文

共 5 条

[1] Can quality of clinical trials and meta-analyses be quantified?
Ioannidis, JPA
Lau, J
[J]. LANCET, 1998, 352 (9128) : 590 - 591
[2] Systematic reviews in health care -: Assessing the quality of controlled clinical trials
Jüni, P
Altman, DG
Egger, M
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7303): : 42 - 46
[3] Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
Moher, D
Pham, B
Jones, A
Cook, DJ
Jadad, AR
Moher, M
Tugwell, P
Klassen, TP
[J]. LANCET, 1998, 352 (9128) : 609 - 613
[4] EMPIRICAL-EVIDENCE OF BIAS - DIMENSIONS OF METHODOLOGICAL QUALITY ASSOCIATED WITH ESTIMATES OF TREATMENT EFFECTS IN CONTROLLED TRIALS
SCHULZ, KF
CHALMERS, I
HAYES, RJ
ALTMAN, DG
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (05): : 408 - 412
[5] SYSTEMATIC REVIEW - WHY SOURCES OF HETEROGENEITY IN METAANALYSIS SHOULD BE INVESTIGATED
THOMPSON, SG
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 309 (6965): : 1351 - 1355